Institution statistics

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - France 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
2018
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:100-200
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Networking Rank (Reputation):100-200
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:400-500
Networking Rank (Reputation):300-400
Partner Constancy:300-400
Project Leadership Index:500-600
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):900-1000
2013
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:200-300
Total Number of Projects:64
Total Project Funding:100-200
Partner Constancy:50
Project Leadership Index:69
Diversity Index:41
2012
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:61
Total Project Funding:100-200
Networking Rank (Reputation):200-300
Networking Rank (Reputation):200-300
Partner Constancy:43
Project Leadership Index:66
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Total Project Funding:200-300
Networking Rank (Reputation):400-500
Partner Constancy:300-400
Project Leadership Index:300-400
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Total Project Funding:400-500
Networking Rank (Reputation):300-400
Partner Constancy:> 1000
Project Leadership Index:300-400
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Total Project Funding:400-500
Networking Rank (Reputation):400-500
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:400-500
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:300-400
Total Number of Projects:800-900
Total Project Funding:200-300
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 99
As coordinator: 4
As participant: 95
Sole participant: 0
Coordinator / Participant Ratio: 0.04*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 13.997.284 782.079 2
2020 0 81.826.342 3.301.321 8
2019 0 114.449.159 4.589.318 8
2018 0 150.283.901 5.341.154 15
2017 6.189.570 92.235.116 4.033.568 1 11
2016 0 11.598.619 772.835 3
2015 0 42.287.851 2.200.779 8
2014 4.500.962 5.206.530 1.468.803 1 3
2013 0 88.682.255 4.213.364 10
2012 5.900.000 62.332.099 4.348.146 1 10
2011 0 78.648.314 2.043.179 11
2010 5.983.478 49.989.501 2.785.675 1 6
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE35
UNIVERSITY COLLEGE LONDON22
CHARITE UNIVERSITAETSMEDIZIN BERLIN16
STICHTING KATHOLIEKE UNIVERSITEIT16
UNIVERSITY OF NEWCASTLE UPON TYNE16
SERVICIO MADRILENO DE SALUD14
KATHOLIEKE UNIVERSITEIT LEUVEN13
UNIVERSITAET ULM13
UNIVERSITAIR MEDISCH CENTRUM UTRECHT13
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK12
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM12
INSERM TRANSFERT12
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN12
KING'S COLLEGE LONDON11
COMMISSARIAT A L'ENERGIE ATOMIQUE10
UNIVERSITA DEGLI STUDI DI TORINO10
ACADEMISCH ZIEKENHUIS GRONINGEN9
REGION HOVEDSTADEN9
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD9
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA8
KAROLINSKA INSTITUTE8
THE UNIVERSITY OF LIVERPOOL8
UNIVERSITA DEGLI STUDI DI PADOVA8
UNIVERSITY OF BOLOGNA8
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM7
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER7
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA7
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE7
NOVARTIS PHARMA7
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER6
INSTITUT CATALA DE LA SALUT6
INSTITUT PASTEUR6
MEDIZINISCHE UNIVERSITAET WIEN6
OSPEDALE PEDIATRICO BAMBINO GESU6
THE UNIVERSITY OF NOTTINGHAM6
UNIVERSITA CATTOLICA DEL SACRO CUORE6
UNIVERSITAETSKLINIKUM HEIDELBERG6
UNIVERSITE DE GENEVE6
UNIVERSITEIT ANTWERPEN6
UNIVERSITY OF BERGEN6
UNIVERSITY OF BIRMINGHAM6
UNIVERSITY OF DUNDEE6
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE5
EBERHARD KARLS UNIVERSITAET TUEBINGEN5
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O5
HOSPICES CIVILS DE LYON5
MEDIZINISCHE HOCHSCHULE HANNOVER5
OSLO UNIVERSITETSSYKEHUS HF5
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON5
SERVICIO ANDALUZ DE SALUD5
THE UNIVERSITY OF EDINBURGH5
UNIVERSITAET BERN5
UNIVERSITAIR ZIEKENHUIS ANTWERPEN5
UNIVERSITE PARIS DESCARTES5
UNIVERSITY OF GLASGOW5
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER5
ARTTIC4
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES4
DEPARTMENT OF HEALTH4
DEUTSCHES KREBSFORSCHUNGSZENTRUM4
ELI LILLY AND COMPANY LIMITED4
ETABLISSEMENT FRANCAIS DU SANG4
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER4
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
GENETHON4
GENOME RESEARCH4
GOETEBORGS UNIVERSITET4
HACETTEPE UNIVERSITESI4
HEALTH SERVICE EXECUTIVE HSE4
ISTITUTO ORTOPEDICO RIZZOLI4
ISTITUTO SUPERIORE DI SANITA4
JANSSEN PHARMACEUTICA NV4
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT4
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS4
THE UNIVERSITY OF SHEFFIELD4
UNIVERSITA DEGLI STUDI DI MILANO4
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA4
UNIVERSITAET LEIPZIG4
UNIVERSITAETSKLINIKUM AACHEN4
UNIVERSITAETSKLINIKUM FREIBURG4
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS4
UNIVERSITE LIBRE DE BRUXELLES4
UNIVERSITY OF BRISTOL4
UNIVERSITY OF COPENHAGEN4
UPPSALA UNIVERSITET4
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS3
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM3
CENTRE DE REGULACIO GENOMICA3
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE3
CENTRO DE INVESTIGACION BIOMEDICA EN RED3
CONCENTRIS RESEARCH MANAGEMENT3
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE3
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV3
EATRIS ERIC3
EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE3
EUROPEAN LIVER PATIENTS ASSOCIATION3
FINOVATIS3
FONDAZIONE STELLA MARIS3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
Constancy:

Total number of partners:1773

Partner loyalty:
Frequent Partner: (> 2 projects): 777
Rare Partner: 996

Frequent / Rare Partner Ratio: 0.78

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES26
RTD HORIZONTAL TOPICS16
PROTECTING MAN AND HIS ENVIRON1

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases GenoMed4ALLparticipant9.999.06423
2021-01-01European-Japanese Virtual Coach for Smart Ageing e-VITAparticipant3.998.22013
2020-12-01Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic: ORCHESTRA ORCHESTRAparticipant19.887.64226
2020-08-01Robust Automation and Point of Care IDentification of COVID RAPID-COVIDparticipant2.832.5855
2020-07-01European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases EU-RESPONSEparticipant15.719.45021
2020-04-01DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES DECISIONparticipant6.000.00021
2020-03-16Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic I-MOVE-COVID-19participant2.808.16326
2020-01-01Screening for liver fibrosis - population-based study across European countries LiverScreenparticipant5.996.48119
2020-01-01Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy CANDYparticipant6.000.00016
2020-01-01Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis DIAMONDSparticipant22.582.02128
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95336
2019-09-01The First Responder (FR) of the Future: a Next Generation Integrated Toolkit (NGIT) for Collaborative Response, increasing protection and augmenting operational capacity INGENIOUSparticipant8.616.11123
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMparticipant6.700.00021
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99827
2019-01-01NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients NECESSITYparticipant8.200.00026
2019-01-01EURopean wide Innovative Procurement of Health Innovation EURIPHIparticipant1.997.34125
2019-01-01ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY iReceptor Plusparticipant7.856.92520
2019-01-01European Joint Programme on Rare Diseases EJP RDparticipant55.073.83189
2018-11-01COllaborative Consortium for the early detection of LIver CANcer COCLICANparticipant450.8008
2018-06-01Network Of practitioners For Emergency medicAl systems and cRitical care NO FEARparticipant3.495.95818
2018-06-01Autism Innovative Medicine Studies – 2 – Trials AIMS-2-TRIALSparticipant54.999.99948
2018-05-01Immunome project consortium for AutoInflammatory Disorders ImmunAIDparticipant15.835.85125
2018-04-01Improving the care of patients suffering from acute or chronic pain IMI-PainCareparticipant11.225.27140
2018-01-01Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome CureCNparticipant6.249.10411
2018-01-01Personalised maxillofacial bone regeneration MAXIBONEparticipant5.949.66512
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2018-01-01Improved Methods and Actionable Tools for Enhancing Health Technology Assessment IMPACT HTAparticipant4.593.30615
2018-01-01Immune Signatures for Therapy Stratification in Major Mood Disorders MOODSTRATIFICATIONparticipant5.963.75012
2018-01-01The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients EU-TRAINparticipant6.641.54612
2018-01-01Solving the unsolved Rare Diseases Solve-RDparticipant15.361.62123
2018-01-01Infradev - European Paediatric Translational Research Infrastructure ID-EPTRIparticipant3.000.00029
2018-01-01How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model RECAGEparticipant2.824.03819
2018-01-01Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative R-LiNKparticipant7.702.53221
2017-12-01Repurposing of carbamazepine for treatment of skeletal dysplasia MCDS-Therapyparticipant5.697.39110
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-09-01Targeting the metabolism-immune system connections in Cancer META-CANparticipant3.831.95820
2017-09-01An INtegrated next generation PREParedness programme for improving effective inter-organisational response capacity in complex environments of disasters and causes of crises IN-PREPparticipant7.999.55620
2017-06-01PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088 PEVIAcoordinator6.189.57014
2017-01-01HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making HarmonicSSparticipant9.998.75039
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2017-01-01SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS LIVERHOPEparticipant5.998.80018
2017-01-01Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF) ALIVERparticipant6.478.73811
2017-01-013-O-sulfated heparan sulfate translocation in altered membrane biology: A new strategy for early population screening and halting Alzheimer’s neurodegeneration ArrestADparticipant3.991.0968
2017-01-01REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy RESPINEparticipant5.555.83615
2017-01-01Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection HIVACARparticipant6.685.11115
2016-10-01Expanding and extending gene therapy of monogenic diseases of the haematopoietic system GENE FOR CUREparticipant2.445.2682
2016-02-01Decision Support and Information Management System for Breast Cancer DESIREEparticipant3.340.72012
2016-01-01Imaging the Force of Cancer FORCEparticipant5.812.63116
2015-11-01EVA - patient ventilation beyond limits EVAparticipant1.890.0005
2015-10-01Innovative training network: Immunoprofile-directed stratification of patients with the autoimmune disorder thrombotic thrombocytopenic purpura PROFILEparticipant1.464.3989

overview shows latest 50 from 99 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:
  • ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum